News Conference News AHA 2017 DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy Yael L. Maxwell November 12, 2017
News Conference News AHA 2017 Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals Todd Neale November 12, 2017
News Conference News AHA 2017 Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many Todd Neale November 11, 2017
Presentation AHA 2017 One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study Presenter: Zuzana Motovska November 11, 2017
Presentation Cardiovascular Interventions 2017 PCI for STEMI Patients With Multivessel Disease: Fix The Culprit or All Lesions? Presenter: Cindy L. Grines November 10, 2017
News Daily News Transradial Access in Primary PCI on the Upswing in the US but Still Uneven Caitlin E. Cox November 10, 2017
News Conference News AHA 2017 AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More Shelley Wood November 09, 2017
Presentation TCT 2017 Case #2 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni November 01, 2017
Presentation TCT 2017 Case #2 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni November 01, 2017
Presentation TCT 2017 Case #1 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora November 01, 2017
Presentation TCT 2017 Case #1 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora November 01, 2017
Presentation TCT 2017 Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Presenter: Samir R. Kapadia, Ioanna Kosmidou November 01, 2017
Presentation TCT 2017 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Samir R. Kapadia, David J. Moliterno November 01, 2017
Presentation TCT 2017 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Samir R. Kapadia, Sameer Gafoor November 01, 2017
Presentation TCT 2017 Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset Presenter: Samir R. Kapadia, Brian K. Whisenant November 01, 2017
Presentation TCT 2017 Rationale and Potential Role for LAA Closure in the PCI and ACS Patient Presenter: Samir R. Kapadia, Ashish Pershad November 01, 2017
Presentation TCT 2017 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Deepak L. Bhatt, C. Michael Gibson, Pascal Vranckx November 01, 2017
Presentation TCT 2017 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status Presenter: Deepak L. Bhatt, C. Michael Gibson, Renato D. Lopes November 01, 2017
Presentation TCT 2017 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice Presenter: Deepak L. Bhatt, C. Michael Gibson November 01, 2017
Presentation TCT 2017 Case #6 (With Discussion): STEMI and an Intact Fibrous Cap Presenter: Henning Kelbæk, Renu Virmani, Ik-Kyung Jang November 01, 2017